Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OVARIAN CARCINOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1264 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lin, JT; Lachmann, E; Nagler, W
      Paraneoplastic cerebellar degeneration as the first manifestation of cancer

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    2. Kim, SJ; Uehara, H; Karashima, T; Mccarty, M; Shih, N; Fidler, IJ
      Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

      NEOPLASIA
    3. Smith, SK
      Angiogenesis and reproduction

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    4. Schneider, J; Gonzalez-Roces, S; Pollan, M; Lucas, R; Tejerina, A; Martin, M; Alba, A
      Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy

      BREAST CANCER RESEARCH
    5. Kriangkum, J; Xu, BW; Nagata, LP; Fulton, RE; Suresh, MR
      Bispecific and bifunctional single chain recombinant antibodies

      BIOMOLECULAR ENGINEERING
    6. Zufia, L; Aldaz, A; Castellanos, C; Giraldez, J
      Simple and rapid determination of carboplatin in plasma by highperformanceliquid chromatography. Error pattern and application to clinical pharmacokinetic studies

      JOURNAL OF CHROMATOGRAPHY B
    7. Kartalou, M; Essigmann, JM
      Mechanisms of resistance to cisplatin

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    8. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    9. Tenev, T; Marani, M; McNeish, I; Lemoine, NR
      Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasomeinhibitors

      CELL DEATH AND DIFFERENTIATION
    10. Matsumoto, Y; Ishiko, O; Deguchi, M; Nakagawa, E; Ogita, S
      Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    11. Hartmann, F; Renner, C; Jung, W; da Costa, L; Tembrink, S; Held, G; Sek, A; Konig, J; Bauer, S; Kloft, M; Pfreundschuh, M
      Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: Role of infusion schedule and costimulation with cytokines

      CLINICAL CANCER RESEARCH
    12. Takahashi, A; Kono, K; Amemiya, H; Iizuka, H; Fujii, H; Matsumoto, Y
      Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer

      CLINICAL CANCER RESEARCH
    13. Kurz, C; Tempfer, CB; Boecskoer, S; Unfried, G; Nagele, F; Hefler, LA
      The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage

      JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    14. Afify, AM; Ferguson, AW; Davila, RM; Werness, BA
      Expression of CD44S and CD44v5 is more common in stage III than in stage Iserous ovarian carcinomas

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    15. Fowers, KD; Callahan, J; Byron, P; Kopecek, JI
      Preparation of Fab' from murine IgG2a for thiol reactive conjugation

      JOURNAL OF DRUG TARGETING
    16. Geisler, JP; Geisler, HE
      Tumor markers and molecular biological markers in gynecologic malignancies

      CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
    17. Giavazzi, R; Taraboletti, G
      Preclinical development of metalloproteasis inhibitors in cancer therapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    18. Zoli, W; Ricotti, L; Tesei, A; Barzanti, F; Amadori, D
      In vitro preclinical models for a rational design of chemotherapy combinations in human tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    19. Minko, T; Kopeckova, P; Kopecek, J
      Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin

      MACROMOLECULAR SYMPOSIA
    20. Shimizu, Y; Utsugi, K; Umezawa, S; Shimizu, K; Hasumi, K; Suzuki, M; Takaku, F
      Effect of human urinary macrophage colony-stimulating factor on the immunefunctions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy

      ONCOLOGY REPORTS
    21. Fujioka, T; Takebayashi, Y; Kihana, T; Kusanagi, Y; Hamada, K; Ochi, H; Uchida, T; Fukumoto, M; Ito, M
      Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma

      ONCOLOGY REPORTS
    22. Skirnisdottir, I; Sorbe, B; Karlsson, M; Seidal, T
      Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    23. Yoshida, H; Ishiko, O; Sumi, T; Matsumoto, Y; Ogita, S
      Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas

      INTERNATIONAL JOURNAL OF ONCOLOGY
    24. Sarantaus, L; Auranen, A; Nevanlinna, H
      BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families

      INTERNATIONAL JOURNAL OF ONCOLOGY
    25. Sarantaus, L; Vahteristo, P; Bloom, E; Tamminen, A; Unkila-Kallio, L; Butzow, R; Nevanlinna, H
      BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients

      EUROPEAN JOURNAL OF HUMAN GENETICS
    26. Chen, FD; Hsieh, BT; Wang, HE; Ou, YH; Yang, WK; Whang-Peng, J; Liu, RS; Knapp, FF; Ting, G; Yen, SH
      Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals

      NUCLEAR MEDICINE AND BIOLOGY
    27. Downer, JD; Jones, LA; Engelbach, JA; Lich, LL; Mao, W; Carlson, KE; Katzenellenbogen, JA; Welch, MJ
      Comparison of animal models for the evaluation of radiolabeled androgens

      NUCLEAR MEDICINE AND BIOLOGY
    28. Pizzato, M; Blair, ED; Fling, M; Kopf, J; Tomassetti, A; Weiss, RA; Takeuchi, Y
      Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells

      GENE THERAPY
    29. Varda-Bloom, N; Shaish, A; Gonen, A; Levanon, K; Greenbereger, S; Ferber, S; Levkovitz, H; Castel, D; Goldberg, I; Afek, A; Kopolovitc, Y; Harats, D
      Tissue-specific gene therapy directed to tumor angiogenesis

      GENE THERAPY
    30. Guven, K; Kittler, H; Wolff, K; Pehamberger, H
      Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients

      MELANOMA RESEARCH
    31. Cemazar, M; Miklavcic, D; Mir, LM; Belchradek, J; Bonnay, M; Fourcault, D; Sersa, G
      Electrochemotherapy of tumours resistant to cisplatin: a study in a murinetumour model

      EUROPEAN JOURNAL OF CANCER
    32. Davidson, B; Reich, R; Berner, A; Givant-Horwitz, V; Goldberg, I; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M; Kopolovic, J; Nesland, JM
      Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

      EUROPEAN JOURNAL OF CANCER
    33. Shiah, JG; Dvorak, M; Kopeckova, P; Sun, Y; Peterson, CM; Kopecek, J
      Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice

      EUROPEAN JOURNAL OF CANCER
    34. Oberhoff, C; Hoffmann, O; Winkler, UH; Schindler, AE
      Hemostatic effects of high-dose megestrol acetate therapy in patients withadvanced gynecological cancer

      GYNECOLOGICAL ENDOCRINOLOGY
    35. Acquati, F; Morelli, C; Cinquetti, R; Bianchi, MG; Porrini, D; Varesco, L; Gismondi, V; Rocchetti, R; Talevi, S; Possati, L; Magnanini, C; Tibiletti, MG; Bernasconi, B; Daidone, MG; Shridhar, V; Smith, DI; Negrini, M; Barbanti-Brodano, G; Taramelli, R
      Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27

      ONCOGENE
    36. Zhang, DM; Vuocolo, S; Masciullo, V; Sava, T; Giordano, A; Soprano, DR; Soprano, KJ
      Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression

      ONCOGENE
    37. Vikhanskaya, F; Bani, MR; Borsotti, P; Ghilardi, C; Ceruti, R; Ghisleni, G; Marabese, M; Giavazzi, R; Broggini, M; Taraboletti, G
      p73 overexpression increases VEGF and reduces thrombospondin-1 production:implications for tumor angiogenesis

      ONCOGENE
    38. Ruangpanit, N; Chan, D; Holmbeck, K; Birkedal-Hansen, H; Polarek, J; Yang, CL; Bateman, JF; Thompson, EW
      Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMPexpression and fibrillar collagen form

      MATRIX BIOLOGY
    39. Vizcaino, I; Torregrosa, A; Higueras, V; Morote, V; Cremades, A; Torres, V; Olmos, S; Molins, C
      Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature

      EUROPEAN RADIOLOGY
    40. Chung, P; Allerton, R
      Malignant meningitis secondary to ovarian carcinoma: An unusual occurrence

      CLINICAL ONCOLOGY
    41. Perego, P; Corna, E; De Cesare, M; Gatti, L; Polizzi, D; Pratesi, G; Supino, R; Zunino, F
      Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines

      CURRENT MEDICINAL CHEMISTRY
    42. Mastrobattista, E; Kapel, RHG; Eggenhuisen, MH; Roholl, PJM; Crommelin, DJA; Hennink, WE; Storm, G
      Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells

      CANCER GENE THERAPY
    43. Weinrib, L; Li, JH; Donovan, J; Huang, D; Liu, FF
      Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma

      CANCER GENE THERAPY
    44. Shmueli, E; Leider-Trejo, L; Schwartz, I; Aderka, D; Inbar, M
      Primary papillary serous carcinoma of the peritoneum in a man

      ANNALS OF ONCOLOGY
    45. Kimmig, R; Wimberger, P; Kapsner, T; Hillemanns, P
      Flow cytometric DNA analysis using cytokeratin labeling for identificationof tumor cells in carcinomas of the breast and the female genital tract

      ANALYTICAL CELLULAR PATHOLOGY
    46. Ohta, M; Konno, H; Tanaka, T; Baba, M; Kamiya, K; Oba, K; Kaneko, T; Syouji, T; Igarashi, A; Nakamura, S
      Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    47. Higashi, T; Sasagawa, T; Inoue, M; Oka, R; Leng, SY; Saijoh, K
      Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma

      JAPANESE JOURNAL OF CANCER RESEARCH
    48. Gerschenson, M; Paik, CY; Gaukler, EL; Diwan, BA; Poirier, MC
      Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses

      REPRODUCTIVE TOXICOLOGY
    49. Luisi, S; Florio, P; Reis, FM; Petraglia, F
      Expression and secretion of activin A: possible physiological and clinicalimplications

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    50. Edmonson, JH; Suman, VJ; Dalton, RJ; Bro, WC; Gallenberg, MM; Long, HJ; Levitt, R; Hatfield, AK; Krook, JE; Mailliard, JA; Gerstner, JB
      Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study

      CANCER INVESTIGATION
    51. Mangiarotti, F; Miotti, S; Galmozzi, E; Mazzi, M; Sforzini, S; Canevari, S; Tomassetti, A
      Functional effect of point mutations in the alpha-folate receptor gene of CABA I ovarian carcinoma cells

      JOURNAL OF CELLULAR BIOCHEMISTRY
    52. Pejovic, T; Koul, A; Olsen, D; Chambers, JT
      NoBRCA1 germline mutation in a family with uterine papillary serous carcinoma: A case report

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    53. Umesaki, N; Tanaka, T; Miyama, M; Ogita, S; Ochi, H
      Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    54. Halperin, R; Zehavi, S; Dar, P; Habler, L; Hadas, E; Bukovsky, I; Schneider, D
      Clinical and molecular comparison between borderline serous ovarian tumorsand advanced serous papillary ovarian carcinomas

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    55. Yuce, K; Baykal, C; Genc, C; Al, A; Ayhan, A
      Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    56. Haughney, RVM; Slade, RJ; Brain, AN
      An isolated abdominal wall metastasis of ovarian carcinoma ten years afterprimary surgery

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    57. Wang, PH; Yuan, CC; Juang, CM; Lai, CR; Yen, MS; Chao, HT; Ng, HT
      Primary epithelial ovarian carcinoma in Taiwanese women

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    58. Wakahara, F; Kikkawa, F; Nawa, A; Tamakoshi, K; Ino, K; Maeda, O; Kawai, M; Mizutani, S
      Diagnostic efficacy of tumor markers, sonography, and intraoperative frozen section for ovarian tumors

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    59. Cormio, G; di Vagno, G; Melilli, GA; Loverro, G; Cramarossa, D; Selvaggi, L
      Ovarian carcinoma metastatic to the breast

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    60. Matsushita, H; Kurabayashi, T; Tomita, M; Yamamoto, Y; Aoki, Y; Tanaka, K
      Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    61. Kikuchi, T; Sugawara, Y; Kajihara, M; Nakata, S; Mochizuki, T; Ikezoe, J; Katayama, T
      Accumulation of Tc-99m HMDP in ovarian serous papillary adenocarcinoma reflecting ongoing calcification

      CLINICAL NUCLEAR MEDICINE
    62. Tinger, A; Waldron, T; Peluso, N; Katin, NJ; Dosoretz, DE; Blitzer, PH; Rubenstein, JH; Garton, GR; Nakfoor, BA; Patrice, SJ; Chuang, L; Orr, JW
      Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    63. Morgan, RJ; Synold, T; Carr, BI; Doroshow, JH; Womack, EP; Shibata, S; Somlo, G; Raschko, J; Leong, L; McNamara, M; Chow, W; Tetef, M; Margolin, K; Akman, S; Longmate, J
      Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    64. Nakayama, K; Kanzaki, A; Takebayashi, Y; Toi, M; Bando, H; Nabei, T; Miyazaki, K; Fukumoto, M
      Different features of angiogenesis between ovarian and breast carcinoma

      CANCER LETTERS
    65. Wurl, P; Fittkau, M; Meye, A; Bartel, F; Schmidt, H; Schonfelder, M; Taubert, H
      Low detection rate of p53 antibodies in sera of soft tissue sarcoma patients

      CANCER LETTERS
    66. Alves, F; Borchers, U; Padge, B; Augustin, H; Nebendahl, K; Kloppel, G; Tietze, LF
      Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model

      CANCER LETTERS
    67. Son, KK; Rosenblatt, J
      Overexpression of protein kinase A-RI alpha reduces lipofection efficiencyof cisplatin-resistant human tumor cells

      CANCER LETTERS
    68. Goldberg, H; Stein, ME; Steiner, M; Sprecher, E; Beck, D; Kuten, A
      Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: Long-term follow-up

      TUMORI
    69. Ikeda, K; Miura, K; Himeno, S; Imura, N; Naganuma, A
      Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    70. Karlsson, G; Nygren, P; Glimelius, B
      Economic aspects of chemotherapy

      ACTA ONCOLOGICA
    71. Hamana, S; Motoyama, S; Takeuchi, S; Ku, Y; Yoshida, S; Miyahara, Y; Tateiwa, Y; Maruo, T
      Super high-dose intraarterial cisplatin infusion under percutaneous pelvicperfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma - I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    72. Giblin, J; Fanucchi, MP; McGuire, WP
      Clear cell carcinoma of the ovary - A remarkable case

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    73. Che, MX; Tornos, C; Deavers, MT; Malpica, A; Gershenson, DM; Silva, EG
      Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    74. Baergen, RN; Warren, CD; Isacson, C; Ellenson, LH
      Early uterine serous carcinoma: Clonal origin of extrauterine disease

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    75. Smith, NL; Halliday, BE; Finley, JL; Wennerberg, AEK
      Immunohistochemical distribution of tumor-associated antigen CA6 in gynecological neoplasms as detected by monoclonal antibody DS6

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    76. Davidson, B; Goldberg, I; Kopolovic, J; Gotlieb, WH; Givant-Horwitz, V; Nesland, JM; Berner, A; Ben-Baruch, G; Bryne, M; Reich, R
      Expression of angiogenesis-related genes in ovarian carcinoma - A clinicopathologic study

      CLINICAL & EXPERIMENTAL METASTASIS
    77. Koshiyama, M; Fujii, H; Kinezaki, M; Morita, Y; Nanno, H; Yoshida, M
      Immunohistochemical expression of topoisomerase II alpha (Topo II alpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas

      ANTICANCER RESEARCH
    78. Koshiyama, M; Fujii, H; Kinezaki, M; Yoshida, M
      Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas

      ANTICANCER RESEARCH
    79. Pohl, G; Suchomel, RW; Stranzl, T; Depisch, D; Stiglbauer, W; Filipits, M; Pirker, R
      Expression of the lung resistance protein in primary colorectal carcinomas

      ANTICANCER RESEARCH
    80. Kopecek, J; Kopeckova, P; Minko, T; Lu, ZR; Peterson, CM
      Water soluble polymers in tumor targeted delivery

      JOURNAL OF CONTROLLED RELEASE
    81. Kasuya, Y; Lu, ZR; Kopeckova, P; Minko, T; Tabibi, SE; Kopecek, J
      Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates

      JOURNAL OF CONTROLLED RELEASE
    82. Minko, T; Kopeckova, P; Kopecek, J
      Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells

      JOURNAL OF CONTROLLED RELEASE
    83. Konecny, G; Untch, M; Slamon, D; Beryt, M; Kahlert, S; Felber, M; Langer, E; Lude, S; Hepp, H; Pegram, M
      Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples

      BREAST CANCER RESEARCH AND TREATMENT
    84. Sowery, RD; Jensen, C; Morrison, KB; Horsman, DE; Sorensen, PHB; Webber, EM
      Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver

      CANCER GENETICS AND CYTOGENETICS
    85. Gross, E; Kiechle, M; Arnold, N
      Mutation analysis of p53 in ovarian rumors by DHPLC

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    86. Perico, ME; Chinol, M; Nacca, A; Luison, E; Paganelli, G; Canevari, S
      The humoral immune response to macrocyclic chelating agent DOTA depends onthe carrier molecule

      JOURNAL OF NUCLEAR MEDICINE
    87. Colgan, TJ; Murphy, J; Cole, DEC; Narod, S; Rosen, B
      Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    88. Seiden, MV; Spitzer, TR; McAfee, S; Fuller, AF
      Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    89. Cormio, G; Cormio, MD; Di Gesu, G; Loverro, G; Selvaggi, L
      Calyceal rupture and perirenal urinoma as a presenting sign of recurrent ovarian cancer

      GYNECOLOGIC ONCOLOGY
    90. Erzen, M; Rakar, S; Klancar, B; Syrjanen, K
      Endometriosis-associated ovarian carcinoma (EAOC): An entity distinct fromother ovarian carcinomas as suggested by a nested case-control study

      GYNECOLOGIC ONCOLOGY
    91. Kheterpal, P; Singh, M; Mondul, A; Dharmarajan, L; Soni, A
      Malignant pericardial effusion and cardiac tamponade in endometrial adenocarcinoma

      GYNECOLOGIC ONCOLOGY
    92. Van Trappen, PO; Pepper, MS
      Lymphangiogenesis and lymph node microdissemination

      GYNECOLOGIC ONCOLOGY
    93. Rieder, J; Jahnke, R; Schloesser, M; Seibel, M; Czechowski, M; Marth, C; Hoffmann, G
      Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines

      GYNECOLOGIC ONCOLOGY
    94. Tseng, CJ; Jain, S; Hou, HC; Liu, WW; Pao, CC; Lin, CT; Horng, SG; Soong, YK; Hsueh, S
      Applications of the telomerase assay in peritoneal washing fluids

      GYNECOLOGIC ONCOLOGY
    95. Cormio, G; Di Vagno, G; Di Fazio, F; Loverro, G; Selvaggi, L
      Intramedullary spinal cord metastasis from ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    96. Davidson, B; Nesland, JM; Goldberg, I; Kopolovic, J; Gotlieb, WH; Byrne, M; Ben-Baruch, G; Berner, A; Reich, R
      Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study

      GYNECOLOGIC ONCOLOGY
    97. Bristow, RE; Duska, LR; Montz, FJ
      The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

      GYNECOLOGIC ONCOLOGY
    98. Ng, JS; Han, AC; Edelson, MI; Rosenblum, NG
      Uterine papillary serous carcinoma presenting as distant lymph node metastasis

      GYNECOLOGIC ONCOLOGY
    99. Hirai, M; Nakagawara, A; Oosaki, T; Hayashi, Y; Hirono, M; Yoshihara, T
      Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma

      GYNECOLOGIC ONCOLOGY
    100. Toy, EP; Chambers, JT; Kacinski, BM; Flick, MB; Chambers, SK
      The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma

      GYNECOLOGIC ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 00:36:35